These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 483408)

  • 1. [Tamoxifen (Nolvadex): therapeutic effect in metastasizing breast cancer].
    Mouridsen HT; Palshof T; Patterson J; Battersby L
    Ugeskr Laeger; 1979 Jul; 141(31):2108-13. PubMed ID: 483408
    [No Abstract]   [Full Text] [Related]  

  • 2. An evaluation of tamoxifen dose escalation in advanced breast cancer.
    Goldhirsch A; Joss RA; Leuenberger U; Cavalli F; Ryssel HJ; Brunner KW
    Am J Clin Oncol; 1982 Oct; 5(5):501-3. PubMed ID: 7180828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Endocrine treatment of metastasizing breast cancer in menopausal women. A randomized comparison between tamoxifen (Nolvadex) versus tamoxifen and medroxyprogesterone acetate (Clinovir)].
    Mouridsen HT; Ellemann K; Mattsson W; Palshof T; Daehnfeldt J; Rose C
    Ugeskr Laeger; 1979 Jul; 141(31):2113-6. PubMed ID: 483409
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of tamoxifen-medroxyprogesterone acetate sequential therapy in 22 patients with recurrent breast cancer].
    Noguchi S; Yamamoto H; Inaii H; Koyama H
    Gan To Kagaku Ryoho; 1989 Nov; 16(11):3555-8. PubMed ID: 2530936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of adriablastine in the combined chemotherapy of breast cancer patients with bone metastases].
    Korman DB; Borisov AI; Maslova IA; Dobroskok LB
    Vopr Onkol; 1980; 26(8):20-4. PubMed ID: 7415044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting response to tamoxifen in metastatic breast cancer.
    Connor JL; Foley JF; Lemon HM
    Nebr Med J; 1986 Dec; 71(12):422-6. PubMed ID: 3796760
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antiestrogens: a new endocrine treatment possibility in metastasizing breast neoplasms. Experiences of the Swiss Cooperative Cancer Study Group with tamoxifen].
    Jungi WF; Alberto P; Wagenknecht L; Cavalli F; Martz G; Brunner KW
    Schweiz Med Wochenschr; 1978 Aug; 108(34):1317-21. PubMed ID: 694481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-oestrogen therapy for breast cancer--a report on 300 patients treated with tamoxifen.
    Ward HW; Arthur K; Banks AJ; Bond WH; Brown I; Freeman WE; Holme GM; Jones WG; Newsholme GA; Ostrowski MJ
    Clin Oncol; 1978 Mar; 4(1):11-7. PubMed ID: 639375
    [No Abstract]   [Full Text] [Related]  

  • 9. [High-dose gestagen therapy in breast cancer].
    Beaufort F; Fereberger W
    Wien Med Wochenschr; 1983 Apr; 133(7):169-73. PubMed ID: 6223450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with progestins and tamoxifen in advanced breast cancer: A preliminary report.
    Trodella L; Ausilli-Cefaro GP; Turriziani A; Saccheri S; Venturo I; Minotti G
    Am J Clin Oncol; 1982 Oct; 5(5):495-9. PubMed ID: 6217741
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II trial with bleomycin, CCNU, and streptozotocin in patients with metastatic cancer of the breast.
    Band PR; Canellos GP; Sears M; Israel L; Pocock SJ
    Cancer Treat Rep; 1977 Oct; 61(7):1365-7. PubMed ID: 73416
    [No Abstract]   [Full Text] [Related]  

  • 12. High-dose tamoxifen in breast cancer bone metastasis.
    Stathopoulos GP; Trafalis D
    J BUON; 2013; 18(2):532-4. PubMed ID: 23818373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparison of two doses of tamoxifen in patients with advanced breast cancer: 20 mg/day versus 40 mg/day].
    Takatsuka Y; Yayoi E; Inaji H; Aikawa T
    Gan To Kagaku Ryoho; 1989 May; 16(5):2093-7. PubMed ID: 2658841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of the effectiveness of zitazonium].
    Borisov VI; Voznyĭ EK; Korobkova LI
    Sov Med; 1983; (6):39-41. PubMed ID: 6351283
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tamoxifen in treating disseminated breast cancer].
    Dement'eva NP; Ass NIa; Koroleva LA; Lipovich MM; Stsetsevich NV
    Vopr Onkol; 1981; 27(8):30-4. PubMed ID: 7281591
    [No Abstract]   [Full Text] [Related]  

  • 16. [High dose cisplatin combination chemotherapy for advanced breast cancer--a report on 50 cases].
    Zhou JC
    Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):215-7. PubMed ID: 8261870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metastatic breast cancer: a comparative study of the efficacy of tamoxifen and the sequential administration of tamoxifen and medroxyprogesterone acetate].
    Giralt E; Jouve M; Palangie T; Bretaudeau B; Asselain B; Magdelenat H; Merle S; Zajdela A; Pouillart P
    Bull Cancer; 1984; 71(1):22-9. PubMed ID: 6324934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of mitomycin-C and tamoxifen (MT) versus dibromodulcitol, adriamycin, and tamoxifen (DAT).
    Chang YC; Falkson G; Tormey DC; Crowley J
    Am J Clin Oncol; 1982 Oct; 5(5):521-5. PubMed ID: 7180830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of drug-resistant metastasizing cancer of the breast with an antiestrogen].
    Frederiksen PL; Engelholm A; Mouridsen HT
    Ugeskr Laeger; 1978 Oct; 140(43):2639-41. PubMed ID: 360540
    [No Abstract]   [Full Text] [Related]  

  • 20. [Progestational agents and bone metastasis in breast cancer].
    Leriche N; Bonneterre J
    Bull Cancer; 1997 Sep; 84(9):891-4. PubMed ID: 9435812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.